Literature DB >> 29969811

Transoral Spine Surgery - an Update.

Jens Castein1, Christoph-Heinrich Hoffmann1, Frank Kandziora1.   

Abstract

Even though in recent years the number of transoral spinal interventions has decreased in Europe and North America - mainly because of the progress in the drug therapy of rheumatism, there are still pathologies that can only be addressed by a transoral approach. The classical transoral approach can be expanded in collaboration with oral-maxillofacial surgery and ear, nose and throat surgery, but this is rarely necessary. The transoral approach is now mainly used for resection of pathological tissue. Additional stabilisation is often necessary and is performed in Europe and North America via a posterior approach, due to the lack of availability of anterior plate systems. Anterior plate systems are still used in India and China. In these countries, the numbers of transoral operations are generally still increasing. Today the indications for transoral spinal surgery consist mainly of infections and tumours, and more rarely of trauma and congenital malformations of the craniocervical junction. The numbers of surgical interventions for these indications has remained constant in recent years. The most recent advancement is the use of endoscopes and transnasal access. With these techniques, additional alternatives and supplements are available for further reducing the morbidity of transoral surgery. Despite the low number of cases, surgical therapy of the corresponding pathologies can be offered to patients with a calculable risk. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 29969811     DOI: 10.1055/a-0621-9430

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  1 in total

1.  Individualized perioperative management in transoral spine surgery: a single-center cohort study evaluating surgical wound complications and wound infections.

Authors:  Vera Spatenkova; David Sila; Milada Halacova; Jan Hradil; Zdenek Krejzar; Eduard Kuriscak
Journal:  BMC Anesthesiol       Date:  2022-04-27       Impact factor: 2.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.